The Beginning of Ending Hepatitis C Virus: A Summary of the 26th International Symposium on Hepatitis C Virus and Related Viruses

Cited 0 time in webofscience Cited 0 time in scopus
  • Hit : 77
  • Download : 0
Hepatitis C virus (HCV) infects similar to 71 million people worldwide, and 399,000 people die annually due to HCV-related liver cirrhosis and hepatocellular carcinoma. The use of direct-acting antivirals results in a sustained virologic response in >95% of patients with chronic HCV infection. However, several issues remain to be solved to eradicate HCV. At the 26th International Symposium on Hepatitis C Virus and Related Viruses (HCV2019) held in Seoul, South Korea, October 5-8, 2019, virologists, immunologists, and clinical scientists discussed these remaining issues and how we can achieve the elimination of HCV.
Publisher
MDPI
Issue Date
2020-03
Language
English
Article Type
Article
Citation

VIRUSES-BASEL, v.12, no.3

ISSN
1999-4915
DOI
10.3390/v12030302
URI
http://hdl.handle.net/10203/274128
Appears in Collection
MSE-Journal Papers(저널논문)
Files in This Item
There are no files associated with this item.

qr_code

  • mendeley

    citeulike


rss_1.0 rss_2.0 atom_1.0